Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Fasching

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Genes, Chromosomes & Cancer|April 1, 1994
Evidence that wild-type TP53, and not genes on either chromosome 1 or 11, controls the tumorigenic phenotype of the human fibrosarcoma HT1080M J Anderson, G Casey, C L Fasching, et al.
Molecular Cell|February 21, 2015
Top3-Rmi1 dissolve Rad51-mediated D loops by a topoisomerase-based mechanismClare L Fasching, Petr Cejka, Stephen C Kowalczykowski, et al.
Nature Genetics|December 2, 2000
Telomere maintenance by recombination in human cellsM A Dunham, A A Neumann, C L Fasching, et al.
Cancer Research|July 27, 2007
DNA damage induces alternative lengthening of telomeres (ALT) associated promyelocytic leukemia bodies that preferentially associate with linear telomeric DNAClare L Fasching, Axel A Neumann, Alessandra Muntoni, et al.
Genes, Chromosomes & Cancer|November 1, 1990
Irradiation microcell-mediated chromosome transfer (XMMCT): the generation of specific chromosomal arm deletionsS F Dowdy, D J Scanlon, C L Fasching, et al.
Radiation Research|July 1, 1995
Loss of a putative tumor suppressor locus after gamma-ray-induced neoplastic transformation of HeLa x skin fibroblast human cell hybridsM S Mendonca, C L Fasching, E S Srivatsan, et al.
Genes, Chromosomes & Cancer|April 1, 1994
Chromosome 13 transfer provides evidence for regulation of RB1 protein expressionM J Anderson, C L Fasching, H J Xu, et al.
Cancer Research|January 15, 1994
Analysis of the tumor suppressor activity of the K-rev-1 gene in human tumor cell linesK Y Sato, P G Polakis, H Haubruck, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 25, 1996
Loss of oncogenic ras expression does not correlate with loss of tumorigenicity in human cellsR Plattner, M J Anderson, K Y Sato, et al.
The Journal of Applied Laboratory Medicine|February 27, 2021
Analytical Validation of Relative Average Telomere Length Measurement in a Clinical Laboratory EnvironmentMarsha N Blauwkamp, Clare L Fasching, Jue Lin, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Genes, Chromosomes & Cancer|April 1, 1994
Evidence that wild-type TP53, and not genes on either chromosome 1 or 11, controls the tumorigenic phenotype of the human fibrosarcoma HT1080M J Anderson, G Casey, C L Fasching, et al.
Molecular Cell|February 21, 2015
Top3-Rmi1 dissolve Rad51-mediated D loops by a topoisomerase-based mechanismClare L Fasching, Petr Cejka, Stephen C Kowalczykowski, et al.
Nature Genetics|December 2, 2000
Telomere maintenance by recombination in human cellsM A Dunham, A A Neumann, C L Fasching, et al.
Cancer Research|July 27, 2007
DNA damage induces alternative lengthening of telomeres (ALT) associated promyelocytic leukemia bodies that preferentially associate with linear telomeric DNAClare L Fasching, Axel A Neumann, Alessandra Muntoni, et al.
Genes, Chromosomes & Cancer|November 1, 1990
Irradiation microcell-mediated chromosome transfer (XMMCT): the generation of specific chromosomal arm deletionsS F Dowdy, D J Scanlon, C L Fasching, et al.
Radiation Research|July 1, 1995
Loss of a putative tumor suppressor locus after gamma-ray-induced neoplastic transformation of HeLa x skin fibroblast human cell hybridsM S Mendonca, C L Fasching, E S Srivatsan, et al.
Genes, Chromosomes & Cancer|April 1, 1994
Chromosome 13 transfer provides evidence for regulation of RB1 protein expressionM J Anderson, C L Fasching, H J Xu, et al.
Cancer Research|January 15, 1994
Analysis of the tumor suppressor activity of the K-rev-1 gene in human tumor cell linesK Y Sato, P G Polakis, H Haubruck, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 25, 1996
Loss of oncogenic ras expression does not correlate with loss of tumorigenicity in human cellsR Plattner, M J Anderson, K Y Sato, et al.
The Journal of Applied Laboratory Medicine|February 27, 2021
Analytical Validation of Relative Average Telomere Length Measurement in a Clinical Laboratory EnvironmentMarsha N Blauwkamp, Clare L Fasching, Jue Lin, et al.
Pageof 3